RED GLEAD DISCOVERY

Red Glead Discovery performs integrated drug discovery. Focusing on small molecules and peptides, our drug discovery platform ranges from medicinal chemistry and synthesis to ADME and biology. The services are supported by Computational Chemistry as well as advanced MS and NMR analysis, also available as stand-alone services. Fragment-based drug discovery is an import area of expertise where we offer access for clients and partners to our proprietary technique WAC (Weak Affinity Chromatography) in combination with other FBDD techniques and methods. Our project management skills and cross-disciplinary capabilities make us a preferred partner for clients and partners that want to develop...

Drug discovery,fragment-based lead discovery,medicinal chemistry,isotope labelling,assay development & screening,bioanalysis,custom synthesis,patent strategies of small molecules and peptides,nmr,adme,and peptide chemistry

Red glead discovery operates in the Pharmaceutical manufacturing industry.

Red glead discovery's revenue is 11m - 100m

Red glead discovery has 51 - 200 employees.